Ignite Creation Date:
2024-05-06 @ 2:46 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04425135
Status:
NOT_YET_RECRUITING
Last Update Posted:
2020-06-11
First Post:
2020-06-08
Brief Title:
Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy Pemetrixed Carboplatin in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC
Sponsor:
The First Affiliated Hospital of Xiamen University
Organization:
The First Affiliated Hospital of Xiamen University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Neoplasms |
Keywords: